CVS HEALTH Corp Cash And Cash Equivalents At Carrying Value

• CVS HEALTH Corp showed a decrease of -1.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from CVS HEALTH Corp's annual report (Form 10-K), filed with the SEC on February 10, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q3 2009: $1.13 billion | Q1 2010: $1.05 billion | Q2 2010: $1.11 billion | Q3 2010: $979.00 million | Q1 2011: $2.16 billion | Q2 2011: $2.23 billion | Q3 2011: $1.71 billion | Q1 2012: $2.21 billion | Q2 2012: $1.82 billion | Q3 2012: $1.23 billion | Q1 2013: $1.55 billion | Q2 2013: $1.17 billion | Q3 2013: $1.51 billion | Q1 2014: $2.77 billion | Q2 2014: $1.61 billion | Q3 2014: $1.13 billion | Q1 2015: $1.52 billion | Q2 2015: $1.24 billion | Q3 2015: $2.89 billion | Q1 2016: $1.78 billion | Q2 2016: $1.13 billion | Q3 2016: $2.19 billion | Q1 2017: $2.22 billion | Q2 2017: $2.09 billion | Q3 2017: $2.49 billion | Q1 2018: $42.02 billion | Q2 2018: $43.82 billion | Q3 2018: $41.59 billion | Q1 2019: $5.90 billion | Q2 2019: $6.06 billion | Q3 2019: $5.19 billion | Q1 2020: $10.08 billion | Q2 2020: $14.87 billion | Q3 2020: $9.26 billion | Q1 2021: $5.60 billion | Q2 2021: $7.12 billion | Q3 2021: $9.83 billion | Q1 2022: $8.44 billion | Q2 2022: $12.12 billion | Q3 2022: $17.20 billion | Q1 2023: $14.62 billion | Q2 2023: $13.81 billion | Q3 2023: $13.04 billion | Q1 2024: $9.80 billion | Q2 2024: $12.51 billion | Q3 2024: $6.88 billion | Q1 2025: $10.08 billion | Q2 2025: $11.79 billion | Q3 2025: $9.10 billion.
• Over the full 16 years of available data (2010 to 2025), CVS HEALTH Corp's Cash And Cash Equivalents At Carrying Value has grown by 492.4%.
• Historical annual values: Fiscal year 2025: $8.45 billion | Fiscal year 2024: $8.59 billion | Fiscal year 2023: $8.20 billion | Fiscal year 2022: $12.95 billion | Fiscal year 2021: $9.41 billion | Fiscal year 2020: $7.85 billion | Fiscal year 2019: $5.68 billion | Fiscal year 2018: $4.06 billion | Fiscal year 2017: $1.70 billion | Fiscal year 2016: $3.37 billion | Fiscal year 2015: $2.46 billion | Fiscal year 2014: $2.48 billion | Fiscal year 2013: $4.09 billion | Fiscal year 2012: $1.38 billion | Fiscal year 2011: $1.41 billion | Fiscal year 2010: $1.43 billion.
• Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: August 10, 2026